David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
H&R Block
HRB
$6.62B
| $62.3M | 0.04% |
1,134,593
+172,575
| +18% | +$9.97M |
|
452
West Pharmaceutical
WST
$24.8B
| $62.2M | 0.04% |
284,336
+181,314
| +176% | +$38.8M |
|
|
KKR.PRD
453
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.42B
| $61.8M | 0.04% |
1,154,000
-646,000
| -36% | -$31.7M |
|
454
CALL
Fair Isaac
FICO
$25.3B
| $61.8M | 0.04% |
33,800
-14,200
| -30% | -$26.7M |
|
455
Aon
AON
$75.3B
| $61.7M | 0.04% |
172,969
+91,041
| +111% | +$33M |
|
456
Riot Platforms
RIOT
$7.44B
| $61.6M | 0.04% |
5,455,200
-1,270,463
| -19% | -$10.8M |
|
457
PUT
Merck
MRK
$376B
| $61.5M | 0.04% |
777,200
+255,800
| +49% | +$20.3M |
|
458
Altria Group
MO
$110B
| $61.4M | 0.04% |
1,047,733
+421,910
| +67% | +$24.8M |
|
459
Aflac
AFL
$58.2B
| $61.4M | 0.04% |
582,082
+505,908
| +664% | +$53.2M |
|
460
BioMarin Pharmaceuticals
BMRN
$12.9B
| $61.3M | 0.04% |
1,115,428
+569,653
| +104% | +$33.5M |
|
461
Woodward
WWD
$20.3B
| $61.2M | 0.04% |
249,841
+246,255
| +6,867% | +$50.4M |
|
462
Teleflex
TFX
$5.88B
| $60.9M | 0.04% |
514,730
-14,485
| -3% | -$1.83M |
|
463
DraftKings
DKNG
$13B
| $60.9M | 0.04% |
1,420,355
-942,600
| -40% | -$33.8M |
|
464
PUT
General Motors
GM
$77.2B
| $60.9M | 0.04% |
1,237,700
-401,600
| -24% | -$19M |
|
465
iShares China Large-Cap ETF
FXI
$4.28B
| $60.6M | 0.04% |
1,649,685
+1,111,852
| +207% | +$38.9M |
|
466
PUT
Strategy Inc
MSTR
$47.4B
| $60.6M | 0.04% |
150,000
| – | – |
|
467
PUT
DoorDash
DASH
$96.8B
| $60.6M | 0.04% |
245,700
-47,500
| -16% | -$9.53M |
|
468
Adient
ADNT
$1.54B
| $60.5M | 0.04% |
3,110,355
+569,320
| +22% | +$8.42M |
|
469
PUT
PayPal
PYPL
$52.7B
| $60.4M | 0.04% |
812,100
+300,800
| +59% | +$20.6M |
|
470
CME Group
CME
$98.9B
| $60.3M | 0.04% |
218,937
-93,891
| -30% | -$25.5M |
|
471
Iron Mountain
IRM
$36.3B
| $59.9M | 0.04% |
583,977
-233,469
| -29% | -$22M |
|
472
Sherwin-Williams
SHW
$84.1B
| $59.8M | 0.04% |
174,202
-439,671
| -72% | -$152M |
|
473
PUT
Estee Lauder
EL
$36.9B
| $59.6M | 0.04% |
737,500
-629,700
| -46% | -$40.5M |
|
474
Thomson Reuters
TRI
$45.7B
| $59.5M | 0.04% |
291,371
+102,334
| +54% | +$19.5M |
|
|
OKLO
475
CALL
Oklo
OKLO
$7.83B
| $58.9M | 0.04% |
1,051,300
-38,700
| -4% | -$1.49M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.